A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
Active, not recruiting · NCT04540497 · Registry updated 2025-12-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease | Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder | Active, not recruiting | Phase 3 | 2025-12-11 | NCT04540497 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Viela Bio Investigative Siite | Tlalpan | Mexico | 1 |